Short description
Valo Health is a technology company focused on utilizing large scale data and AI-driven computation to discover and develop therapeutics.
Description
Valo Health, Inc (Valo) is a technology company focused on utilizing large scale data and AI-driven computation to discover and develop therapeutics. Valo aims to fully integrate human-centric data across the entire drug development life cycle into a single unified architecture, thereby accelerating the discovery and development of life-changing drugs while simultaneously reducing costs, time, and failure rates. The company’s Opal Computational Platform™ is an end-to-end drug discovery and development platform with a unified architecture designed to transform data into valuable insights that may accelerate discoveries and enable Valo to advance a robust pipeline of programs, initially focused on cardiovascular metabolic renal, oncology, and neurodegenerative disease. Founded by Flagship Pioneering and headquartered in Boston, MA, Valo also has offices in Lexington, MA, and New York, NY. To learn more, visit valohealth.com.
Last funding
Noaccessforu
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Boston, Massachusetts, United States, North America
Founded on
January 1, 2019
Non-profit?
No
Acquired?
No
Employees count
101-250
Revenue range
$56378 - 90123
Sign in for full access
Investors
Absolutely Noaccess, Noaccess, Absolutely Noaccess, Blurry Noaccess, Noway Youcantaccess, Noway Youcantaccess, Blurry Noaccess, Absolutely Noaccess, Blurry Noaccess
Sign in for full access
Founders
David Berry, Noubar Afeyan